Results 221 to 230 of about 216,439 (378)

Secondary malignancies after chronic myeloid leukaemia upon TKI treatment: Population trends and outcomes

British Journal of Haematology, EarlyView.
A retrospective study from 11 institutions was performed in 139 chronic myeloid leukaemia (CML) patients with secondary malignancies. The median ages at diagnosis of CML and secondary malignancy were 51 years (range, 13–88 years) and 53 years (range, 18–91 years). After a median follow‐up of 85 months, the median time from diagnosis of CML to secondary
Yingling Zu, Xipeng Yue, Xinrong Zhan, Xiaojuan Liu, Hongxia Ma, Fuli Qin, Lijuan Duan, Hongmian Zhao, Yan Zhang, Shiqiang He, Huifang Zhao, Chunlei Zhang, Xiangke Xin, Wenli Zhang, Yongping Song, Bingcheng Liu, Weiming Li, Yanli Zhang   +17 more
wiley   +1 more source

Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact—a study of 784 patients from the Quebec MPN research group

Blood Cancer Journal
Alisa Poullet, Lambert Busque, Shireen Sirhan, Robert Delage, Ghislain Cournoyer, Ines Chamakhi, Danielle Talbot, Luigina Mollica, Daniele Marceau, Vincent Ethier, Pierre Desjardins, Harold J. Olney, Michaël Harnois, Natasha Szuber   +13 more
doaj   +1 more source

Surgical management of giant splenomegaly in chronic myeloid leukemia: a challenging splenectomy case. [PDF]

J Surg Case Rep
Alqatta W.
europepmc   +1 more source

Sustained molecular remission in a patient with CML in blastic crisis receiving dose‐reduced hematopoietic stem‐cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon‐α [PDF]

, 2002
Tamae Hamaki, Masahiro Kami, Shin‐ichi Momomura, Shin Mineishi, Eiji Kusumi, Yoshinobu Kanda, Junichi Ueyama, Shigesaburo Miyakoshi, Shinichi Morinaga, Yoichi Takaue, Yoshitomo Mutou   +10 more
openalex   +1 more source

Homoharringtonine Promotes FTO Degradation to Suppress LILRB4‐Mediated Immune Evasion in Acute Monocytic Leukaemia

Cell Proliferation, EarlyView.
Homoharringtonine (HHT) suppresses immune evasion in acute monocytic leukaemia (AML‐M5) by attenuating the FTO/m6A/LILRB4 axis, thereby enhancing CD8+ T cell cytotoxicity. ABSTRACT Acute monocytic leukaemia, a subtype of acute myeloid leukaemia (AML), is a highly aggressive malignancy characterised by a poor prognosis, primarily due to the ability of ...
Fangfang Huang, Xiang Luo, Mengyu Zhang, Le Jin, Wenxin Sun, Peihan Chen, Xiuli Hong, Chenyu Xu, Meizhi Jiang, Die Hu, Bin Zhang, Shengwei Hu, Chuanjiang Yang, Rui Gao, Jinzhang Zeng, Quanyi Lu, Qiang Luo, Jun Wu, Siming Chen   +18 more
wiley   +1 more source

HIF2-α Expression in CML Patients Receiving Hydroxyurea Prior to Imatinib That Achieved Major Molecular Response (MMR) versus in Those Not Achieving MMR

Journal of Blood Medicine
Ikhwan Rinaldi,1,2 Radinal Mauludi,2 Sri Widia Jusman,3 Robert Sinto,4 Kuntjoro Harimurti5,6 1Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas ...
Rinaldi I, Mauludi R, Jusman SW, Sinto R, Harimurti K   +4 more
doaj  

Testing methods used to predict disease progression in children with early‐stage type 1 diabetes: A systematic review and meta‐analysis

Diabetic Medicine, EarlyView.
Abstract Aims Current guidance on how best to monitor children and young people (CYP) with early‐stage type 1 diabetes is evidenced mainly by expert consensus. This systematic review and meta‐analysis aims to evaluate the current evidence for tests used to predict disease progression. Methods Data were sourced from PubMed, Cochrane Central, Ovid Embase
Rabbi Swaby, Kruthika Narayan, Claire Scudder, Julia Townson, Richard A. Oram, Kirstine J. Bell, Maria E. Craig, Colin Dayan, Paul Aveyard, Rachel E. J. Besser   +9 more
wiley   +1 more source

Bcr-abl kinase inhibition as the basis of therapy for cml

, 2000
Brian J. Druker, Moshe Talpaz, Debra Resta, Bin Peng, Eliasbeth Buchdunger, J. Ford, Charles L. Sawyers   +6 more
openalex   +1 more source

Activation of the c-Jun N-terminal Kinase (JNK) Signaling Pathway Is Essential during PBOX-6-induced Apoptosis in Chronic Myelogenous Leukemia (CML) Cells [PDF]

, 2002
Margaret M. Mc Gee, Giuseppe Campiani, Anna Ramunno, Vito Nacci, Mark Lawler, D. Clive Williams, Daniela M. Zisterer   +6 more
openalex   +1 more source

Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries

Journal of Cancer Research and Clinical Oncology, 2017
J. Geissler, G. Sharf, F. Bombaci, Mina Daban, J. D. Jong, Tony Gavin, J. Pelouchová, E. Dziwiński, J. Hasford, V. Hoffmann   +9 more
semanticscholar   +1 more source